In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d

Research output: Contribution to journalArticlepeer-review

Abstract

SOURCE CITATION: Wagenlehner FM, Gasink LB, McGovern PC, et al; CERTAIN-1 Study Team. Cefepime-taniborbactam in complicated urinary tract infection. N Engl J Med. 2024;390:611-622. 38354140.

Original languageEnglish (US)
Pages (from-to)JC67
JournalAnnals of internal medicine
Volume177
Issue number6
DOIs
StatePublished - Jun 1 2024

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d'. Together they form a unique fingerprint.

Cite this